Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FUSED HETEROCYCLIC DERIVATIVE HAVING HIV REPLICATION INHIBITORY ACTION
Document Type and Number:
WIPO Patent Application WO/2023/033018
Kind Code:
A1
Abstract:
The present invention provides a compound represented by formula (I). (In the formula, A1, A2, or A3 each independently is a carbon atom or a nitrogen atom, B1, B2, B3, or B4 each independently is a carbon atom or a nitrogen atom, X1 is CR4R5, etc., R4 or R5 each independently is hydrogen, etc., X2 is CR7R8, etc., R7 or R8 each independently is hydrogen, etc., R1 is a substituted or unsubstituted aromatic carbocyclic group, etc., R2 each independently is hydroxy, etc., R3 each independently is hydroxy, etc., n is an integer of 0-3, and m is an integer of 0-4.)

Inventors:
TADANO GENTA (JP)
YASUO KAZUYA (JP)
OKANO AZUSA (JP)
KUSUMOTO YOSHIFUMI (JP)
MASAKADO SOTA (JP)
Application Number:
PCT/JP2022/032701
Publication Date:
March 09, 2023
Filing Date:
August 31, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHIONOGI & CO (JP)
International Classes:
C07D498/14; A61K31/553; A61P31/12; A61P31/18; C07D513/14; C07D519/00
Foreign References:
US20070249583A12007-10-25
Other References:
STORCK, P. ; AUBERTIN, A.M. ; GRIERSON, D.S.: "Tosylation/mesylation of 4-hydroxy-3-nitro-2-pyridinones as an activation step in the construction of dihydropyrido[3,4-b] benzo[f][1,4]thiazepin-1-one based anti-HIV agents", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM , NL, vol. 46, no. 16, 18 April 2005 (2005-04-18), Amsterdam , NL , pages 2919 - 2922, XP027863019, ISSN: 0040-4039
Attorney, Agent or Firm:
SUGITA Ken-ichi et al. (JP)
Download PDF: